Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

SEEMS THEY ARE READY FOR EUA, YES???

“Although our current production methods yield a drug that is sufficiently stable for emergency use...”

https://www.businesswire.com/news/home/20210309005660/en/NeuroRX-and-TFF-Pharmaceuticals-Announce-Entering-Into-Feasibility-Collaboration

ARE THEY GETTING READY FOR ASTHMA NEXT???
...a long-term, shelf-stable formulation will be needed for ongoing use of ZYESAMI

Once Zyesami (TM) IV and inhaler get approved, what studies follow and how fast??? Drug repurposing??? —————-
--————————
Drug repurposing is one such strategy. Many agents approved for other uses already have been tested in humans, so detailed information is available on their pharmacology, formulation and potential toxicity. Because repurposing builds upon previous research and development efforts, new candidate therapies could be ready for clinical trials quickly, speeding their review by the Food and Drug Administration and, if approved, their integration into health care. ~ NIH > NCATS.

https://ncats.nih.gov/preclinical/repurpose